Form 4 · Filed Jul 20, 2026, 10:00 AM UTC
MLPT/MapLight Therapeutics, Inc.
Kreitzer Anatol — Chief Discovery Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | S | sell | 14,140 | $38 | $533,078 | 175,106 |
| Jul 17, 2026 | S | sell | 2,833 | $37 | $104,963 | 189,246 |
| Jul 17, 2026 | S | sell | 200 | $38 | $7,678 | 174,906 |
| Jul 16, 2026 | S | sell | 1,592 | $37 | $59,604 | 192,079 |
| Jul 16, 2026 | S | sell | 7,464 | $37 | $273,630 | 193,671 |
| Jul 15, 2026 | S | sell | 5,545 | $36 | $200,341 | 205,645 |
| Jul 15, 2026 | S | sell | 4,510 | $37 | $166,599 | 201,135 |
Source: SEC EDGAR raw filing ↗ · Accession 0002021238-26-000010